Infliximab in the treatment of amyloidosis secondary to Crohn's disease

Statistics

Utilidad del infliximab en el tratamiento de la amiloidosis secundaria en la enfermedad de Crohn

J. B.. Cabezueloa, J. Pedro Egeab, F.. Ramosa, E.. Torrellac, S.. Muraya, C.. Alcázara

a Sección de Nefrología, Hospital General Universitario Reina Sofía, Murcia

b Servicio de Medicina Interna, Hospital General Universitario Morales Meseguer, Murcia

c Sección de Medicina Digestiva, Hospital General Universitario Morales Meseguer, Murcia

Read

12905

Times
was read the article

3503

Total PDF

9402

Total HTML

Share statistics

Article information

ISSN: 20132514
Original language: English

DOI:10.3265/Nefrologia.pre2012.Feb.11332

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	135	162	297
2025 5	110	66	176
2025 4	72	51	123
2025 3	116	78	194
2025 2	76	46	122
2025 1	51	41	92
2024 12	42	34	76
2024 11	60	54	114
2024 10	48	51	99
2024 9	61	39	100
2024 8	68	60	128
2024 7	43	47	90
2024 6	48	49	97
2024 5	68	39	107
2024 4	55	39	94
2024 3	43	31	74
2024 2	37	41	78
2024 1	33	35	68
2023 12	17	38	55
2023 11	55	32	87
2023 10	30	36	66
2023 9	34	40	74
2023 8	40	21	61
2023 7	41	40	81
2023 6	37	33	70
2023 5	67	51	118
2023 4	42	28	70
2023 3	62	22	84
2023 2	48	30	78
2023 1	41	27	68
2022 12	39	31	70
2022 11	41	27	68
2022 10	40	37	77
2022 9	57	52	109
2022 8	41	47	88
2022 7	50	45	95
2022 6	62	42	104
2022 5	66	41	107
2022 4	58	59	117
2022 3	46	62	108
2022 2	66	53	119
2022 1	77	35	112
2021 12	36	46	82
2021 11	32	50	82
2021 10	47	51	98
2021 9	38	50	88
2021 8	40	44	84
2021 7	81	43	124
2021 6	34	27	61
2021 5	74	51	125
2021 4	78	70	148
2021 3	76	55	131
2021 2	76	31	107
2021 1	36	29	65
2020 12	40	26	66
2020 11	26	17	43
2020 10	30	21	51
2020 9	32	8	40
2020 8	31	14	45
2020 7	50	10	60
2020 6	66	18	84
2020 5	61	17	78
2020 4	43	20	63
2020 3	43	13	56
2020 2	36	19	55
2020 1	48	17	65
2019 12	55	23	78
2019 11	49	22	71
2019 10	26	12	38
2019 9	40	20	60
2019 8	41	8	49
2019 7	52	27	79
2019 6	105	29	134
2019 5	75	25	100
2019 4	114	43	157
2019 3	68	25	93
2019 2	42	31	73
2019 1	63	34	97
2018 12	127	41	168
2018 11	164	21	185
2018 10	100	17	117
2018 9	84	24	108
2018 8	69	19	88
2018 7	84	24	108
2018 6	71	15	86
2018 5	70	16	86
2018 4	103	7	110
2018 3	90	9	99
2018 2	87	10	97
2018 1	74	6	80
2017 12	113	12	125
2017 11	76	15	91
2017 10	68	12	80
2017 9	86	12	98
2017 8	64	41	105
2017 7	70	32	102
2017 6	83	30	113
2017 5	92	30	122
2017 4	81	31	112
2017 3	67	35	102
2017 2	105	20	125
2017 1	46	25	71
2016 12	106	5	111
2016 11	147	19	166
2016 10	194	11	205
2016 9	285	4	289
2016 8	334	7	341
2016 7	263	15	278
2016 6	185	0	185
2016 5	163	0	163
2016 4	141	0	141
2016 3	132	0	132
2016 2	141	0	141
2016 1	157	0	157
2015 12	163	0	163
2015 11	119	0	119
2015 10	128	0	128
2015 9	122	0	122
2015 8	108	0	108
2015 7	107	0	107
2015 6	48	0	48
2015 5	64	0	64
2015 4	14	0	14

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter